CVMP activities related to antimicrobials

This document outlines ongoing and planned activities in the strategic area of antimicrobial resistance. 

The report is in line with:

• European medicines agencies network strategy to 2028 (theme 4)
• EU's One Health approach

It builds on the previous CVMP strategy on antimicrobials for the period 2021-2025. 

Keywords: Antimicrobial resistance, CVMP, strategy

Current effective version

CVMP activities related to antimicrobials - Status report on EMA/CVMP activities (2021–2025) and EMANS 2028 Strategic Overview (Theme 4)

Adopted Reference Number: EMA/CVMP/144957/2025

Document history

CVMP strategy on antimicrobials 2021-2025

Adopted Reference Number: EMA/CVMP/179874/2020

Overview of comments received on 'CVMP strategy on antimicrobials 2021-2025'

Reference Number: EMA/CVMP/517722/2020

Draft CVMP strategy on antimicrobials 2021-2025

Draft: consultation closed Consultation dates: 01/07/2020 to 30/09/2020 Reference Number: EMA/CVMP/179874/2020 Summary:

The CVMP’s draft strategy on antimicrobials for the period from 2021 to 2025 is now published for public consultation until 30 September 2020. The focus of the CVMP’s activities will be on supporting the effective implementation of those provisions in the Regulation (EU) 2019/6 that take forward the EU’s One Health Action Plan against antimicrobial resistance (AMR).

CVMP strategy on antimicrobials 2016-2020

Adopted Reference Number: EMA/CVMP/209189/2015 Summary:

The Committee adopted the revised CVMP strategy on antimicrobials for the period 2016-2020. The CVMP vision on antimicrobials aims to ensure the availability of effective antimicrobial medicines for the treatment of infectious diseases of animals while, at the same time, minimising the risks to animals or humans arising from their use. The strategy intends to strengthen the benefit-risk assessment for antimicrobial veterinary medicinal products in a One Health context.

Overview of comments received on 'CVMP strategy on antimicrobials 2016-2020' (EMA/CVMP/209189/2015)

Reference Number: EMA/CVMP/185871/2016 Summary:

Following the end of the consultation period of the CVMP strategy on Antimicrobials 2016-2020 the Committee revised the comments received from nine stakeholders. The overview of comments document contains the answers provided by the Committee.

Draft CVMP strategy on antimicrobials 2016-2020

Draft: consultation closed Consultation dates: 17/11/2015 to 29/02/2016 Reference Number: EMA/CVMP/209189/2015 Summary:

The draft Committee for Medicinal Products for Veterinary Use (CVMP) strategy on antimicrobials for 2016-2020 sets clear objectives and course of action for the next five years, based on a 'One Health' approach. The CVMP’s vision is the availability of effective antimicrobial medicines for the treatment of important infectious diseases of animals with, at the same time, minimum risks to animals or humans arising from their use.